Announced Mon, 29 Jun · 11:38 IST
Trading window closed from July 1 for Q1 results
Compliance View source PDF
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.3%1-day move
₹1905.00
prior close
₹1955.90
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.1+0.0-0.4+3.3+2.7+5.2+7.1+5.1+4.3+7.1———
Up moveDown movePending
AI summary
Corona Remedies has closed its trading window from July 1, 2026 until 48 hours after the declaration of unaudited financial results for Q1 ending June 30, 2026. This is a routine SEBI insider trading compliance measure taken ahead of the upcoming quarterly earnings announcement. Insiders including directors, KMPs, and employees cannot trade in company shares during this blackout period. The Board meeting date for considering the Q1 results will be announced separately.
Likely market impact
Routine insider trading compliance. Insiders barred from trading shares until Q1 results are declared. No direct stock impact.